These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 17188357)

  • 21. How do natural killer cells find self to achieve tolerance?
    Yokoyama WM; Kim S
    Immunity; 2006 Mar; 24(3):249-57. PubMed ID: 16546094
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NK cell MHC class I specific receptors (KIR): from biology to clinical intervention.
    Thielens A; Vivier E; Romagné F
    Curr Opin Immunol; 2012 Apr; 24(2):239-45. PubMed ID: 22264929
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ectopically expressed PIR-B on T cells constitutively binds to MHC class I and attenuates T helper type 1 responses.
    Imada M; Masuda K; Satoh R; Ito Y; Goto Y; Matsuoka T; Endo S; Nakamura A; Kawamoto H; Takai T
    Int Immunol; 2009 Oct; 21(10):1151-61. PubMed ID: 19684158
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cis binding between inhibitory receptors and MHC class I can regulate mast cell activation.
    Masuda A; Nakamura A; Maeda T; Sakamoto Y; Takai T
    J Exp Med; 2007 Apr; 204(4):907-20. PubMed ID: 17420263
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin-12 improves cytotoxicity of natural killer cells via upregulated expression of NKG2D.
    Zhang C; Zhang J; Niu J; Zhou Z; Zhang J; Tian Z
    Hum Immunol; 2008 Aug; 69(8):490-500. PubMed ID: 18619507
    [TBL] [Abstract][Full Text] [Related]  

  • 26. How Does the maternal immune system contribute to the development of pre-eclampsia?
    Moffett A; Hiby SE
    Placenta; 2007 Apr; 28 Suppl A():S51-6. PubMed ID: 17292469
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evolutionary vignettes of natural killer cell receptors.
    Sambrook JG; Beck S
    Curr Opin Immunol; 2007 Oct; 19(5):553-60. PubMed ID: 17884420
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antiviral NK cell responses in HIV infection: I. NK cell receptor genes as determinants of HIV resistance and progression to AIDS.
    Iannello A; Debbeche O; Samarani S; Ahmad A
    J Leukoc Biol; 2008 Jul; 84(1):1-26. PubMed ID: 18388298
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cytokine-driven regulation of NK cell functions in tumor immunity: role of the MICA-NKG2D system.
    Zwirner NW; Fuertes MB; Girart MV; Domaica CI; Rossi LE
    Cytokine Growth Factor Rev; 2007; 18(1-2):159-70. PubMed ID: 17324607
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Human histocompatibility HLA system. Considerations in the light of current concepts. II. Immunogenetic function].
    Kedzierska A; Turowski G
    Przegl Lek; 2001; 58(6):509-12. PubMed ID: 11816743
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune-refractory cancers and their little helpers--an extended role for immunetolerogenic MHC molecules HLA-G and HLA-E?
    Wischhusen J; Waschbisch A; Wiendl H
    Semin Cancer Biol; 2007 Dec; 17(6):459-68. PubMed ID: 17768067
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Killer cell immunoglobulin-like receptors influence the innate and adaptive immune responses.
    Rajalingam R
    Iran J Immunol; 2007 Jun; 4(2):61-78. PubMed ID: 17652846
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NKG2D ligands: key targets of the immune response.
    González S; López-Soto A; Suarez-Alvarez B; López-Vázquez A; López-Larrea C
    Trends Immunol; 2008 Aug; 29(8):397-403. PubMed ID: 18602338
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Porcine T lymphocytes and NK cells--an update.
    Gerner W; Käser T; Saalmüller A
    Dev Comp Immunol; 2009 Mar; 33(3):310-20. PubMed ID: 18601948
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MHC class I antigens and immune surveillance in transformed cells.
    Aptsiauri N; Cabrera T; Garcia-Lora A; Lopez-Nevot MA; Ruiz-Cabello F; Garrido F
    Int Rev Cytol; 2007; 256():139-89. PubMed ID: 17241907
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The regulation of lymphocyte activation by inhibitory receptors.
    Leibson PJ
    Curr Opin Immunol; 2004 Jun; 16(3):328-36. PubMed ID: 15134782
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Non-canonical anchor motif peptides bound to MHC class I induce cellular responses.
    Lazoura E; Lodding J; Farrugia W; Day S; Ramsland PA; Apostolopoulos V
    Mol Immunol; 2009 Mar; 46(6):1171-8. PubMed ID: 19118903
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Killer dendritic cells: mechanisms of action and therapeutic implications for cancer.
    Wesa AK; Storkus WJ
    Cell Death Differ; 2008 Jan; 15(1):51-7. PubMed ID: 17948028
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel recognition system for MHC class I molecules constituted by PIR.
    Takai T
    Adv Immunol; 2005; 88():161-92. PubMed ID: 16227090
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immune escape and exploitation strategies of cytomegaloviruses: impact on and imitation of the major histocompatibility system.
    Mocarski ES
    Cell Microbiol; 2004 Aug; 6(8):707-17. PubMed ID: 15236638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.